Institusi dan Kepemilikan Dana - Pembeli
Pemegang saham utama yang telah membuka posisi baru di Neuphoria Therapeutics Inc. termasuk Balyasny Asset Management Llc, Vanguard Capital Management Llc, Squadron Capital Management LLC, Vanguard Fiduciary Trust Co, dan Virtu Financial LLC .
Halaman ini menunjukkan perubahan struktur kepemilikan berdasarkan daftar institusi, dana, dan pemegang saham utama yang telah meningkatkan kepemilikannya atau membuka posisi baru pada periode pelaporan terakhir. Baris hijau menunjukkan posisi baru. Klik tautannya ikon untuk melihat riwayat transaksi lengkap.
Upgrade untuk membuka data premium.
| Tanggal Berkas | Sumber | Investor | Jenis | Harga Rata-rata (Perkiraan) |
Saham | Δ Saham (%) |
Dilaporkan Nilai ($1000) |
Δ Nilai (%) |
Alokasi Portofolio (%) |
|
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | 13F/A | Vanguard Capital Management Llc | 98.516 | 401 | ||||||
| 2026-05-01 | 13F | Lynx1 Capital Management LP | 875.328 | 0,01 | 3.563 | 4,92 | ||||
| 2026-05-05 | 13F | UBS Group AG | 2.316 | 40,19 | 9 | 50,00 | ||||
| 2026-05-15 | 13F/A | Vanguard Fiduciary Trust Co This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value | 33.589 | 137 | ||||||
| 2026-05-14 | 13F | Virtu Financial LLC | 12.033 | 0 | ||||||
| 2026-05-15 | 13F | Geode Capital Management, Llc | 52.007 | 200,57 | 212 | 214,93 | ||||
| 2026-04-28 | 13F | AdvisorShares Investments LLC | 155.367 | 15,78 | 632 | 21,54 | ||||
| 2026-05-15 | 13F | Citadel Advisors Llc | 19.331 | 79 | ||||||
| 2026-05-15 | 13F | Balyasny Asset Management Llc | 142.183 | 579 | ||||||
| 2026-05-15 | 13F | Squadron Capital Management LLC | 76.728 | 312 |
